Camille L. Bedrosian - 27 Nov 2023 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
27 Nov 2023
Net transactions value
$0
Form type
3
Filing time
29 Nov 2023, 16:45:46 UTC
Previous filing
23 Jun 2023
Next filing
18 Apr 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney